Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: Decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality
Open Access
- 30 September 2002
- journal article
- clinical trial
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 8 (9) , 493-500
- https://doi.org/10.1053/bbmt.2002.v8.pm12374454
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: